Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06883357

The Effects of Home-based Graded Repetitive Arm Supplementary Program Group on Stroke.

The Effects of Home-based Graded Repetitive Arm Supplementary Program Group on Stroke: the Randomized Controlled Trial.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
52 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Graded repetitive arm supplementary program (GRASP) is a self administrated, home-based rehabilitation program and has been incorporated in Canadian Stroke Best Practice Recommendations. Past studies indicated that the home-based GRASP program could facilitate the motor function and motor recovery and prevent learned nonuse of affected upper limb of stroke patients. There is lacking of research and application of the home-based GRASP program in Taiwan. Therefore, this study aims to explore the effects of the home-based GRASP program, which is mainly executed in the form of group intervention, on the affected upper limb of stroke patients.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGraded repetitive arm supplementary program (GRASP)Graded repetitive arm supplementary program (GRASP) is a self administrated, home-based rehabilitation program. home-based GRASP program could facilitate the motor function and motor recovery and prevent learned nonuse of affected upper limb of stroke patients. Participants in experimental group will receive Home GRASP program which will be executed 1hour at home per day. In addition, Participants will be requested to return hospital for follow-up and adjusting the training program in group discussion 3 times per week, lasting 4-6 weeks, and totally 12-18 sessions.

Timeline

Start date
2025-03-17
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-03-19
Last updated
2025-04-08

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06883357. Inclusion in this directory is not an endorsement.